ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for charts Cadastre-se para gráficos em tempo real, ferramentas de análise e preços.

CLDX Celldex Therapeutics Inc

38,00
-0,85 (-2,19%)
23 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Celldex Therapeutics Inc CLDX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,85 -2,19% 38,00 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
38,91 37,62 39,67 37,77 38,85
mais cotações »

Notícias Recentes

Data Hora Fonte Título
17/04/202409:01GLOBECelldex Announces Completion of Enrollment in Phase 2 Study..
08/03/202409:00GLOBECelldex Therapeutics to Participate in the Leerink Partners..
05/03/202412:30GLOBECelldex Therapeutics to Present at TD Cowen’s 44th Annual..
05/03/202412:10GLOBECelldex Therapeutics Announces Closing of Public Offering of..
29/02/202423:14GLOBECelldex Therapeutics Announces Pricing of Upsized $400..
28/02/202418:01GLOBECelldex Therapeutics Announces Proposed Public Offering of..
26/02/202409:01GLOBECelldex Reports Fourth Quarter and Year End 2023 Financial..
24/02/202416:05GLOBECelldex Therapeutics Presents Positive 12 Week Results from..
06/02/202418:01GLOBECelldex to Participate in the Guggenheim Healthcare Talks..
05/02/202410:01GLOBECelldex Announces Upcoming Presentation of Barzolvolimab..
27/11/202318:15GLOBECelldex Therapeutics to Present at 6th Annual Evercore ISI..
08/11/202301:15GLOBECelldex Therapeutics Announces Pricing of Public Offering of..
07/11/202318:01GLOBECelldex Therapeutics Announces Proposed Public Offering of..
06/11/202308:30GLOBECelldex Therapeutics Announces Positive Topline Results from..
05/11/202317:00GLOBECelldex Therapeutics Presents Positive Data from Prurigo..
02/11/202317:01GLOBECelldex Reports Third Quarter 2023 Financial Results and..
26/09/202308:01GLOBECelldex Announces Acceptance of Abstract for Barzolvolimab..
25/09/202309:31GLOBECelldex Therapeutics to Present at Cantor Global Healthcare..
08/08/202317:01GLOBECelldex Reports Second Quarter 2023 Financial Results and..
11/07/202309:01GLOBECelldex Announces Completion of Enrollment in Phase 2 Study..
06/07/202309:01GLOBECelldex Announces First Patient Dosed in Phase 2 Study of..
10/06/202311:45GLOBECelldex Therapeutics Presents Positive Data from..
08/06/202317:01GLOBECelldex Therapeutics Announces Upcoming Barzolvolimab..
02/06/202309:01GLOBECelldex Therapeutics to Present at Jefferies Healthcare..
31/05/202309:01GLOBECelldex Announces First Patient Dosed in Phase 1 Study of..
15/05/202309:01GLOBECelldex Therapeutics Presents Positive Preclinical Data from..
04/05/202317:01GLOBECelldex Reports First Quarter 2023 Financial Results and..

Seu Histórico Recente

Delayed Upgrade Clock